Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[Q]: Evolocumab met the main goal of a late-stage trial titled RUTHERFORD-2 by lowering “bad” LDL cholesterol levels when tested against a placebo on 329 patients. Amgen, the world’s biggest biotechnology company, is testing evolocumab widely on a variety of subpopulations. The RUTHERFORD-2 study included patients with familial hypercholesterolemia, an inherited condition that causes high levels of “bad” LDL cholesterol starting at birth. Specifically, patients in the study had heterozygous familial hypercholesterolemia, which is one of the most common genetic disorders affecting about one out of every 300 to 500 people worldwide, according to Amgen. The company on Tuesday reported positive results from a fourth late-stage study of evolocumab, for which it plans to begin seeking approvals this year. The drug is intended for people who cannot tolerate widely used statins, or who are unable to get their LDL levels low enough despite using high potency statins, such as AstraZeneca’s Crestor. Amgen’s shares closed at $120.89 on the Nasdaq on Thursday.
[A]: Amgen's cholesterol fighter succeeds in fifth late-stage study.


[Q]: Amid a scarcity of doctors and public hospitals, India is relying on its mobile telephone network, the second largest in the world with 950 million connections, to reach places where health workers rarely go. “It’s a huge priority for us,” health ministry official Manoj Jhalani told Reuters, adding that the service, advising on vaccinations and vitamin supplements, will launch in eight of the country’s Hindi-speaking states by Aug. 15.”These are the most cost-effective health interventions,” said Jhalani, the supervisor of the project, named ‘Kilkari,’ or “Baby’s Gurgle”, which will tailor its recorded messages to individual stages of pregnancy or the age of a newborn. Poor sanitary conditions and stark poverty prevail in many villages in India, which recorded 50,000 maternal deaths in 2013, when 1.3 million children died before turning five. Preventable hazards such as pneumonia, or poor nutrition, cause most deaths of mothers and babies. Many women give birth at home without access to clean water and toilets, while public medical clinics remain dilapidated and overcrowded. Over the last 18 months, almost 100,000 rural families have signed up for the voice message project, first piloted by the government of the impoverished, but resource-rich, eastern state of Bihar. With India’s health services starved for funds, the mobile phone messages are a cheaper way to spread basic tips on health. Payment delays have led to months of disruption in the traditional system of home visits by health workers to encourage pregnant women to take medicine and follow safety measures. The new project, backed by the Bill and Melinda Gates Foundation and the charity arm of British broadcaster BBC, will make use of a national database to track pregnant women. Another service, Mobile Academy, will also use recorded messages to help train India’s millions of health workers. Health experts welcome the initiatives, but warn such mobile phone campaigns will not be enough to cut mortality rates unless India ramps up health services, particularly in rural areas. “This (mobile services) will have a very marginal effect,” said Dileep Mavalankar, director of the Indian Institute of Public Health in the western state of Gujarat, adding that the health system needed to be strengthened in remote areas.
[A]: India bets on mobiles in battle on maternal, child deaths.


[Q]: Despite struggling with some of the world’s worst air pollution levels, India has already pushed back a deadline to cut emission levels to up to 2022, after extensive lobbying by power producers who cited high costs and technical difficulties. The rejection of the foreign technology comes at a time when over half of coal-fired plants in India are already set to miss a phased deadline starting Dec. 2019 to cut emissions of lung diseases-causing sulphur oxides. State-run NTPC, which generates a quarter of India’s electricity, held talks with foreign firms including General Electric Co, Norway-based Yara International and Japan-based Mitsubishi Hitachi Power Systems over the potential purchase of filters that lower emissions of smog-causing nitrogen oxide. However, none of the pilot tests it conducted met key emissions parameters, NTPC said in a presentation submitted last month to the Central Pollution Control Board. “The pilot tests concluded that both selective non-catalytic reduction (SNCR) and selective catalytic reduction (SCR) technologies currently available are not suitable for installation at power plants in India,” it said in the presentation reviewed by Reuters, referring to technologies used to cut emissions of nitrogen oxides. Thermal power companies produce three-quarters of the country’s electricity and account for some 80% of India’s industrial emissions of sulphur oxides that cause lung diseases and smog-creating nitrogen oxides. NTPC had presented cost estimates in 2016 for the installation of the technology to cut nitrogen oxides throughout its network of power plants. According to Reuters calculations based on those estimates, the cost would total $2.4 billion, although industry consultants said recently that those costs could now be 25% lower. The utility wants a dilution in nitrogen oxide emissions standards and claimed in last month’s presentation that the lowered standards can be achieved with minor retrofits, without the need to install new equipment. The pollution board held a stakeholder meeting on Nov. 7, an audio recording of which was reviewed by Reuters. In the meeting, GE and Yara representatives rejected NTPC’s views, saying their technologies were proven worldwide, according to the recording and two sources present at the meeting. NTPC did not attend the meeting. NTPC, and the Indian units of GE and Yara did not respond to detailed Reuters questionnaires seeking comment. Mitsubishi Hitachi did not immediately respond to a request for comment made on its website. NTPC said in the earlier presentation to the pollution board that high ash content in Indian coal posed challenges to installing SCR technology and that SNCR did not meet key parameters. The foreign companies responded, saying pilot tests were run in a constrained environment and that commercial use of the equipment, which requires some changes to the plant, would cut emissions to the required levels. “The conditions for the (pilot) test was that we can’t touch special parts at all, we can’t touch furnace tubes. NTPC did not allow us,” Senthilvel Rangasamy, a GE representative, said in the meeting. Premchand Talreja, the managing director of the Indian unit of Yara, said the pilot tests achieved the desired results. “There should not be doubt on the technology itself,” Talreja said in the meeting. Lauri Myllyvirta, an analyst at the Centre for Research on Energy and Clean Air and previously a member of a European Union technical working group on emissions by coal-fired utilities, said India has failed to curtail emissions due to “delay and misinformation tactics by the power industry”. “The power industry managed to build a myth that Indian coal is so special that technologies proven on a wide range of coal types elsewhere need to be tested and validated again in India before the standards can be implemented,” Myllyvirta told Reuters.
[A]:
Exclusive: India's NTPC snubs foreign emissions tech, shuts out GE, others from $2 billion orders.